Plasma, blood and liver tissue sample preparation methods for the separate quantification of liposomal-encapsulated prednisolone phosphate and non-encapsulated prednisolone

References

• Bellott R, Pouna P, Robert J. (2001). Separation and determination of liposomal and non-liposomal daunorubicin from the plasma of patients treated with Daunoxome. J Chromatogr B 757:257–67
   PubMed Web of Science ®Google Scholar
• Bennett PK, Van Horne KC. (2003). Identification of the major endogenous and persistent compounds in plasma, serum and tissue that cause matrix effects with electrospray LC/MS techniques. Available from: http://www.tandemlabs.com/documents/AAPS03PB.pdf [last accessed 31 Mar 2014]
   Google Scholar
• Brandenburg JT. (2000). Bloedafname en bloedonderzoek. In: Brandenburg JT, Kramer K, van der Valk J, eds. Proefdierkunde: biotechnisch handboek. Oss, The Netherlands: Stichting Proefdierkundige Informatie, 395–407
   Google Scholar
• Crommelin DJA, Storm G. (2003). Liposomes: from the bench to the bed. J Liposome Res 13:33–6
   PubMed Web of Science ®Google Scholar
• Daemen T, Regts J, Meesters M, et al. (1997). Toxicity of doxorubicin entrapped within long-circulating liposomes. J Control Release 44:1–9
   Web of Science ®Google Scholar
• Druckmann S, Gabizon A, Barenholz Y. (1989). Separation of liposome-associated doxorubicin from non-liposome-associated doxorubicin in human plasma: implications for pharmacokinetic studies. Biochim Biophys Acta 980:381–4
   PubMed Web of Science ®Google Scholar
• Gabizon A, Shmeeda H, Barenholz Y. (2003). Pharmacokinetics of pegylated liposomal doxorubicin. Clin Pharmacokinet 42:419–36
   PubMed Web of Science ®Google Scholar
• Garg V, Jusko WJ. (1994). Bioavailability and reversible metabolism of prednisone and prednisolone in man. Biopharm Drug Dispos 15:163–72
   PubMed Web of Science ®Google Scholar
• Griese N, Blaschke G, Boos J, Hempel G. (2002). Determination of free and liposome-associated daunorubicin and daunorubicinol in plasma by capillary electrophoresis. J Chromatogr A 979:379–88
   Google Scholar
• Hays LM, Crowe JH, Wolkers W, Rudenko S. (2001). Factors affecting leakage of trapped solutes from phospholipid vesicles during thermotropic phase transitions. Cryobiology 42:88–102
   PubMedGoogle Scholar
• Krishna R, Webb MS, St. Onge G, Mayer LD. (2001). Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties. J Pharmacol Exp Ther 298:1206–12
   PubMed Web of Science ®Google Scholar
• Kwon IK, Lee SC, Han B, Park K. (2012). Analysis on the current status of targeted delivery to tumors. J Control Release 164:108–14
   PubMed Web of Science ®Google Scholar
• Laginha KM, Verwoert S, Charrois GJR, Allen TM. (2005). Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors. Clin Cancer Res 11:6944–9
   PubMed Web of Science ®Google Scholar
• Mayer LD, St.-Onge G. (1995). Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques. Anal Biochem 232:149–57
   PubMed Web of Science ®Google Scholar
• Melarange R, Sadra P, Harris A, et al. (2007). The use of Covaris adaptive focused acoustics in psychiatryCEDD DMPK. Available from: http://covarisinc.com/wp-content/uploads/GSK_DMDG_2007.pdf [last accessed on 27 May 2013]
   Google Scholar
• Metselaar JM. (2003). Liposomal targeting of glucocorticoids. A novel treatment approach for inflammatory disorders. Enschede, The Netherlands: PrintPartners Ipskamp B.V
   Google Scholar
• Metselaar JM, Wauben MHM, Wagenaar-Hilbers JPA, et al. (2003). Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthritis Rheum 48:2059–66
   PubMed Web of Science ®Google Scholar
• Möllmann H, Balbach S, Hochhaus G, et al. (1995). Pharmacokinetic-pharmacodynamic correlations of corticosteroids. In: Derendorf H, Hochhaus G, eds. Handbook of pharmacokinetic-pharmacodynamic correlation. Boca Raton: CRC Press, 323–61
   Google Scholar
• Newman MS, Colbern GT, Working PK, et al. (1999). Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice. Cancer Chemother Pharmacol 43:1–7
   PubMed Web of Science ®Google Scholar
• Poulin P, Theil F-P. (2002). Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution. J Pharm Sci 91:129–56
   PubMed Web of Science ®Google Scholar
• Qian S, Li C, Zuo Z. (2012). Pharmacokinetics and disposition of various drug loaded liposomes. Curr Drug Metab 13:372–95
   PubMed Web of Science ®Google Scholar
• Sahin S, Karabey Y, Kaynak MS, Hincal AA. (2006). Potential use of freeze-drying technique for estimation of tissue water content. Methods Find Exp Clin Pharmacol 28:211–15
   Google Scholar
• Samtani MN, Schwab M, Nathanielsz PW, Jusko WJ. (2004). Stabilization and HPLC analysis of betamethasone sodium phosphate in plasma. J Pharm Sci 93:726–32
   Google Scholar
• Schiffelers RM, Metselaar JM, Fens MHAM, et al. (2005). Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice. Neoplasia 7:118–27
   PubMed Web of Science ®Google Scholar
• Smits EAW, Smits CJP, Vromans H. (2013a). The development of a method to quantify encapsulated and free prednisolone phosphate in liposomal formulations. J Pharm Biomed Anal 75:47–54
   PubMed Web of Science ®Google Scholar
• Smits EAW, Soetekouw JA, Vromans H. (2013b). In vitro confirmation of the quantitative differentiation of liposomal encapsulated and non-encapsulated prednisolone (phosphate) tissue concentrations by murine phosphatases. Determination of the dephosphorylation rate of murine phosphatases to enable the quantitative differentiation between liposomal encapsulated and non-encapsulated drug in tissues after administration of liposomal prednisolone phosphate in mice. J Liposome Res [Epub ahead of print]. doi: 10.3109/08982104.2013.850593. Available from: http://informahealthcare.com/lpr [last accessed 9 May 2014]
   Google Scholar
• Srigritsanapol AA, Chan KK. (1994). A rapid method for the separation and analysis of leaked and liposomal entrapped phosphoramide mustard in plasma. J Pharm Biomed Anal 12:961–8
   Google Scholar
• Storm G, Ten Kate MT, Working PK, Bakker-Woudenberg IAJM. (1998). Doxorubicin entrapped in sterically stabilized liposomes: effects on bacterial blood clearance capacity of the mononuclear phagocyte system. Clin Cancer Res 4:111–15
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services, FDA, CDER, Center for Veterinary Medicine. (2001). Guidance for industry: bioanalytical method validation. Available from: http://www.fda.gov/downloads/Drugs/Guidances/ucm070107.pdf [last accessed on 23 Aug 2013]
   Google Scholar
• Van Bommel EMG, Crommelin DJA. (1984). Stability of doxorubicin–liposomes on storage: as an aqueous dispersion, frozen or freeze-dried. Int J Pharm 22:299–310
   Web of Science ®Google Scholar
• Zamboni WC, Strychor S, Joseph E, et al. (2007). Plasma, tumor, and tissue disposition of STEALTH liposomal CKD-602 (S-CKD602) and nonliposomal CKD-602 in mice bearing A375 human melanoma xenografts. Clin Cancer Res 13:7217–23
   PubMed Web of Science ®Google Scholar
• Zolnik BS, Stern ST, Kaiser JM, et al. (2008). Rapid distribution of liposomal short-chain ceramide in vitro and in vivo. Drug Metab Dispos 36:1709–15
   PubMed Web of Science ®Google Scholar